Cargando…
Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy
Cancer has emerged as a leading cause of death worldwide. However, the pursuit of precise cancer therapy and high-efficiency delivery of antitumor drugs remains an enormous obstacle. The major challenge is the lack of a smart drug delivery system with the advantages of biodegradability, biocompatibi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384823/ https://www.ncbi.nlm.nih.gov/pubmed/37514006 http://dx.doi.org/10.3390/pharmaceutics15071820 |
_version_ | 1785081251802120192 |
---|---|
author | Huang, Wenquan Yao, Fei Tian, Shuangyan Liu, Mohao Liu, Guijin Jiang, Yanbin |
author_facet | Huang, Wenquan Yao, Fei Tian, Shuangyan Liu, Mohao Liu, Guijin Jiang, Yanbin |
author_sort | Huang, Wenquan |
collection | PubMed |
description | Cancer has emerged as a leading cause of death worldwide. However, the pursuit of precise cancer therapy and high-efficiency delivery of antitumor drugs remains an enormous obstacle. The major challenge is the lack of a smart drug delivery system with the advantages of biodegradability, biocompatibility, stability, targeting and response release. Zein, a plant-based protein, possesses a unique self-assembly ability to encapsulate anticancer drugs directly or indirectly. Using zein as a nanotherapeutic pharmaceutic preparation can protect anticancer drugs from harsh environments, such as sunlight, stomach acid and pepsin. Moreover, the surface functionalization of zein is easily realized, which can endow it with targeting and stimulus-responsive release capacity. Hence, zein is an ideal nanocarrier for the precise delivery of anticancer drugs. Combined with our previous research experiences, we attempt to review the current state of the preparation of zein-based nanocarriers for anticancer drug delivery. The challenges, solutions and development trends of zein-based nanocarriers for precise cancer therapy are discussed. This review will provide a guideline for precise cancer therapy in the future. |
format | Online Article Text |
id | pubmed-10384823 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103848232023-07-30 Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy Huang, Wenquan Yao, Fei Tian, Shuangyan Liu, Mohao Liu, Guijin Jiang, Yanbin Pharmaceutics Review Cancer has emerged as a leading cause of death worldwide. However, the pursuit of precise cancer therapy and high-efficiency delivery of antitumor drugs remains an enormous obstacle. The major challenge is the lack of a smart drug delivery system with the advantages of biodegradability, biocompatibility, stability, targeting and response release. Zein, a plant-based protein, possesses a unique self-assembly ability to encapsulate anticancer drugs directly or indirectly. Using zein as a nanotherapeutic pharmaceutic preparation can protect anticancer drugs from harsh environments, such as sunlight, stomach acid and pepsin. Moreover, the surface functionalization of zein is easily realized, which can endow it with targeting and stimulus-responsive release capacity. Hence, zein is an ideal nanocarrier for the precise delivery of anticancer drugs. Combined with our previous research experiences, we attempt to review the current state of the preparation of zein-based nanocarriers for anticancer drug delivery. The challenges, solutions and development trends of zein-based nanocarriers for precise cancer therapy are discussed. This review will provide a guideline for precise cancer therapy in the future. MDPI 2023-06-26 /pmc/articles/PMC10384823/ /pubmed/37514006 http://dx.doi.org/10.3390/pharmaceutics15071820 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Huang, Wenquan Yao, Fei Tian, Shuangyan Liu, Mohao Liu, Guijin Jiang, Yanbin Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy |
title | Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy |
title_full | Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy |
title_fullStr | Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy |
title_full_unstemmed | Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy |
title_short | Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy |
title_sort | recent advances in zein-based nanocarriers for precise cancer therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384823/ https://www.ncbi.nlm.nih.gov/pubmed/37514006 http://dx.doi.org/10.3390/pharmaceutics15071820 |
work_keys_str_mv | AT huangwenquan recentadvancesinzeinbasednanocarriersforprecisecancertherapy AT yaofei recentadvancesinzeinbasednanocarriersforprecisecancertherapy AT tianshuangyan recentadvancesinzeinbasednanocarriersforprecisecancertherapy AT liumohao recentadvancesinzeinbasednanocarriersforprecisecancertherapy AT liuguijin recentadvancesinzeinbasednanocarriersforprecisecancertherapy AT jiangyanbin recentadvancesinzeinbasednanocarriersforprecisecancertherapy |